JAMA Oncol in press

Cardiovascular Safety Communications After US Food and Drug
Administration Approval of Contemporary Cancer Therapies.

Bonsu JM, Kola-Kehinde O, Kim L, Ruz P, Campbell CM, Brammer JE, Addison D